Abstract

<div>Abstract<p>Genetic variation at insulin-like growth factor 1 (<i>IGF1</i>) has been linked to prostate cancer risk. However, the specific predisposing variants have not been identified. In this study, we fine-mapped the <i>IGF1</i> locus for prostate cancer risk in African Americans. We conducted targeted Roche GS-Junior 454 resequencing of a 156-kb region of <i>IGF1</i> in 80 African American aggressive prostate cancer cases. Three hundred and thirty-four <i>IGF1</i> SNPs were examined for their association with prostate cancer risk in 1,000 African American prostate cancer cases and 991 controls. The top associated SNP in African Americans, rs148371593, was examined in an additional 3,465 prostate cancer cases and 3,425 controls of non-African American ancestry—European Americans, Japanese Americans, Latinos, and Native Hawaiians. The overall association of 334 <i>IGF1</i> SNPs and prostate cancer risk was assessed using logistic kernel-machine methods. The association between each SNP and prostate cancer risk was evaluated through unconditional logistic regression. A false discovery rate threshold of <i>q</i> < 0.1 was used to determine statistical significance of associations. We identified 8 novel <i>IGF1</i> SNPs. The cumulative effect of the 334 <i>IGF1</i> SNPs was not associated with prostate cancer risk (<i>P</i> = 0.13) in African Americans. Twenty SNPs were nominally associated with prostate cancer at <i>P</i> < 0.05. The top associated SNP among African Americans, rs148371593 [minor allele frequency (MAF) = 0.03; <i>P</i> = 0.0014; <i>q</i> > 0.1], did not reach our criterion of statistical significance. This polymorphism was rare in non-African Americans (MAF < 0.003) and was not associated with prostate cancer risk (<i>P</i> = 0.98). Our findings do not support the role of <i>IGF1</i> variants and prostate cancer risk among African Americans. <i>Cancer Epidemiol Biomarkers Prev; 23(9); 1928–32. ©2014 AACR</i>.</p></div>

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call